Expression of neuron specific enolase in serum of remission patients with diffuse large B-cell lymphoma and its significance
10.3760/cma.j.issn.1009-9921.2014.02.012
- VernacularTitle:神经元特异性烯醇化酶在弥漫大B细胞淋巴瘤缓解患者血清中的表达及其意义
- Author:
Lianxiang CHEN
;
Zhen XIAO
;
Bintao HUANG
;
Wei WANG
- Publication Type:Journal Article
- Keywords:
Lymphoma,large B-cell,diffuse;
Neuron specific enolase;
Serum
- From:
Journal of Leukemia & Lymphoma
2014;23(2):103-106
- CountryChina
- Language:Chinese
-
Abstract:
Objective To examine the expression of neuron-specific enolase (NSE) in patients with remission diffuse large B-cell lymphoma (DLBCL),and to explone its prognostic value.Methods Serum NSE values were mesured by electmchemilumineseence immunoassay in 20 health donors and 40 DLBCL patients reached remission after 6-8 cycles of chemotherapy after initial diagnosis.Results Positive expressions rate of NSE in remission DLBCL patients was 50 %,and was 10 % in health donors (P < 0.01).In remission DLBCL patients,there was significant difference in the 2-year PFS rate between in NSE-positive group and negative group (6.6 % vs 20.9%,P < 0.001).Serum NSE was an independent poor prognostic factor in remission DLBCL patients.Conclusion Serum NSE expressions is an independent poor prognostic factor of remission DLBCL and has significant clinical value.